GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Beginning Cash Position

Kyverna Therapeutics (Kyverna Therapeutics) Beginning Cash Position : $35.21 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics Beginning Cash Position?

Kyverna Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was $35.21 Mil.

Kyverna Therapeutics's quarterly Beginning Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($23.53 Mil) and increased from Dec. 2023 ($23.53 Mil) to Mar. 2024 ($35.21 Mil).

Kyverna Therapeutics's annual Beginning Cash Position increased from Dec. 2021 ($27.54 Mil) to Dec. 2022 ($76.62 Mil) but then declined from Dec. 2022 ($76.62 Mil) to Dec. 2023 ($38.29 Mil).

Kyverna Therapeutics Beginning Cash Position Historical Data

The historical data trend for Kyverna Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics Beginning Cash Position Chart

Kyverna Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
27.54 76.62 38.29

Kyverna Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial 32.06 38.29 - 23.53 35.21

Kyverna Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Kyverna Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics (Kyverna Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Beginning Cash Position
Comparable Companies
Traded in Other Exchanges
N/A
Address
5980 Horton Street, STE 550, Emeryville, CA, USA, 94608
Website
https://www.kyvernatx.com
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR.

Kyverna Therapeutics (Kyverna Therapeutics) Headlines

From GuruFocus

Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering

By PRNewswire • 02-12-2024